From the Department of Anesthesiology, University of Kansas Medical Center, Kansas City, KS.
Reg Anesth Pain Med. 2017 Nov/Dec;42(6):760-763. doi: 10.1097/AAP.0000000000000664.
In 1924, the Therapeutic Research Committee of the American Medical Association appointed a special committee to investigate deaths following the administration of local anesthetics. The Committee for the Study of Toxic Effects of Local Anesthetics found procaine, although a safer clinical alternative to cocaine, was capable of causing death when large doses were injected into tissues and advised that it should be used with caution. This article describes a collaboration beginning in 1928 between Dr John Lundy of the Mayo Clinic and Dr Robert Isenberger of the University of Kansas, which arose from a controversy surrounding systemic adverse reactions to procaine. Isenberger then traveled to the Mayo Clinic to conduct research on various procaine local and spinal anesthesia doses and sodium amytal's protective effect against procaine-induced toxicity. Lundy and Isenberger's work would add to the ongoing discovery of systemic reactions to local anesthetics.
1924 年,美国医学协会治疗研究委员会任命了一个特别委员会,调查局部麻醉剂使用后的死亡情况。局部麻醉剂毒性作用研究委员会发现,普鲁卡因虽然是一种比可卡因更安全的临床替代品,但当大剂量注入组织时也有致人死亡的可能,因此建议谨慎使用。本文描述了 1928 年梅奥诊所的约翰·伦迪博士和堪萨斯大学的罗伯特·艾森伯格博士之间的合作,该合作源于普鲁卡因引起的全身不良反应的争议。艾森伯格随后前往梅奥诊所,研究各种普鲁卡因局部和脊髓麻醉剂量以及苯甲酸钠对普鲁卡因毒性的保护作用。伦迪和艾森伯格的工作将有助于不断发现局部麻醉剂的全身反应。